AGTR2 and cardiovascular disorder: Of interest, expression of the AT2 receptor can be upregulated during pathologic settings such as myocardial infarction and kidney damage (Oishi et al., 2003; Vázquez et al., 2005), which has led to the notion that AT2 receptor agonism may be a novel therapeutic option for cardiovascular disease.